Skip to main content

Table 8 Correlation of METTL3 gene expression level to blast count during follow-up stages for assessment of early response to chemotherapy and maintenance of CR

From: Methyltransferase-like 3 gene (METTL3) expression and prognostic impact in acute myeloid leukemia patients

  METTL3 gene expression (during follow-up)
R p value
Assessment of early response to chemotherapy
 Day 28 BM blast % 0.377 0.037*
Assessment of maintenance of CR
 2nd month BM blast % 0.872 < 0.001**
 4th month BM blast % 0.649 0.016*
 6th month BM blast % 0.833 0.002*
  1. * mean statistically significant value (< 0.05) and ** mean highly statistically significant (< 0.001)